Loading clinical trials...
Loading clinical trials...
The Use of Novel Therapies to Reconstitute Blood Cell Production and Promote Organ Performance Using Bone Marrow Failure as a Model: a Pilot, Phase I/II Study of the Amino Acid Leucine in the Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia
Conditions
Interventions
leucine
Locations
11
United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Stanford University Medical Center
Palo Alto, California, United States
Riley Hospital for Children
Indianapolis, Indiana, United States
University of Louisville
Louisville, Kentucky, United States
Boston Children's Hospital
Boston, Massachusetts, United States
University of Michigan C.S. Mott Children's Hospital
Ann Arbor, Michigan, United States
Start Date
June 1, 2013
Primary Completion Date
June 30, 2018
Completion Date
November 30, 2020
Last Updated
December 2, 2022
NCT07087769
NCT06701617
NCT06875596
NCT07268963
NCT03148600
NCT07393789
Lead Sponsor
Northwell Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions